EMERALD INNOVATION REINVENTING ENTERPRISE LIMITED

Emerald Innovation Reinventing Enterprise Limited is at the forefront of remote health monitoring, offering a touch‑less sensor and machine‑learning platform that turns everyday living spaces into continuous health‑analytics hubs. By installing a discreet device in the home, users are monitored passively – no interaction is required – allowing clinicians to capture rich, objective data on mobility, gait, respiration, sleep quality and stages, as well as broader behavioural patterns.

The company’s solution is purpose‑built for pharmaceutical partners seeking dense, unbiased clinical data. Emerald’s platform has already supported Phase 2 and Phase 4 trials across neurology, immunology and rare‑disease programmes, enabling in‑home studies that reduce patient burden while accelerating data collection. Leading drug developers such as Aspen, Verge, BlueRock Therapeutics and RSRT have praised the technology for delivering continuous, objective measures of disease progression and symptom activity.

Emerald’s blend of sensor hardware, advanced analytics and a collaborative scientific team makes it a trusted ally for organisations aiming to streamline trial design, improve biomarker discovery and bring effective therapies to market faster.